nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—CYP3A7—Dexamethasone—psoriatic arthritis	0.0984	0.147	CbGbCtD
Dextropropoxyphene—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0984	0.147	CbGbCtD
Dextropropoxyphene—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0761	0.114	CbGbCtD
Dextropropoxyphene—CYP2C8—Dexamethasone—psoriatic arthritis	0.071	0.106	CbGbCtD
Dextropropoxyphene—CYP3A4—Triamcinolone—psoriatic arthritis	0.0577	0.0861	CbGbCtD
Dextropropoxyphene—CYP2C9—Dexamethasone—psoriatic arthritis	0.0495	0.0739	CbGbCtD
Dextropropoxyphene—CYP3A4—Betamethasone—psoriatic arthritis	0.0495	0.0739	CbGbCtD
Dextropropoxyphene—CYP3A4—Prednisolone—psoriatic arthritis	0.0488	0.0729	CbGbCtD
Dextropropoxyphene—CYP3A4—Prednisone—psoriatic arthritis	0.0461	0.0689	CbGbCtD
Dextropropoxyphene—CYP2D6—Dexamethasone—psoriatic arthritis	0.0453	0.0676	CbGbCtD
Dextropropoxyphene—CYP3A4—Dexamethasone—psoriatic arthritis	0.0288	0.043	CbGbCtD
Dextropropoxyphene—Drug withdrawal syndrome—Prednisone—psoriatic arthritis	0.00399	0.0122	CcSEcCtD
Dextropropoxyphene—Eye disorder—Auranofin—psoriatic arthritis	0.00396	0.0121	CcSEcCtD
Dextropropoxyphene—Myopathy—Prednisolone—psoriatic arthritis	0.00384	0.0117	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Prednisolone—psoriatic arthritis	0.0038	0.0116	CcSEcCtD
Dextropropoxyphene—Myopathy—Triamcinolone—psoriatic arthritis	0.00353	0.0108	CcSEcCtD
Dextropropoxyphene—Myopathy—Methylprednisolone—psoriatic arthritis	0.00352	0.0108	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Triamcinolone—psoriatic arthritis	0.0035	0.0107	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Methylprednisolone—psoriatic arthritis	0.00349	0.0107	CcSEcCtD
Dextropropoxyphene—Quinapril—ACE—psoriatic arthritis	0.00323	1	CrCbGaD
Dextropropoxyphene—Myopathy—Betamethasone—psoriatic arthritis	0.0032	0.00979	CcSEcCtD
Dextropropoxyphene—Myopathy—Dexamethasone—psoriatic arthritis	0.0032	0.00979	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Dexamethasone—psoriatic arthritis	0.00317	0.0097	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Betamethasone—psoriatic arthritis	0.00317	0.0097	CcSEcCtD
Dextropropoxyphene—Myopathy—Prednisone—psoriatic arthritis	0.00279	0.00853	CcSEcCtD
Dextropropoxyphene—Hepatomegaly—Prednisone—psoriatic arthritis	0.00276	0.00845	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Auranofin—psoriatic arthritis	0.00265	0.00811	CcSEcCtD
Dextropropoxyphene—Constipation—Auranofin—psoriatic arthritis	0.00258	0.00787	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00246	0.00753	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Auranofin—psoriatic arthritis	0.00238	0.00728	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Prednisolone—psoriatic arthritis	0.00231	0.00707	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Prednisolone—psoriatic arthritis	0.00215	0.00659	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Triamcinolone—psoriatic arthritis	0.00213	0.0065	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Methylprednisolone—psoriatic arthritis	0.00212	0.00649	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Prednisolone—psoriatic arthritis	0.00206	0.0063	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Auranofin—psoriatic arthritis	0.00206	0.0063	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Triamcinolone—psoriatic arthritis	0.00198	0.00606	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Methylprednisolone—psoriatic arthritis	0.00198	0.00604	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Betamethasone—psoriatic arthritis	0.00193	0.0059	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Dexamethasone—psoriatic arthritis	0.00193	0.0059	CcSEcCtD
Dextropropoxyphene—Vomiting—Auranofin—psoriatic arthritis	0.00191	0.00585	CcSEcCtD
Dextropropoxyphene—Rash—Auranofin—psoriatic arthritis	0.0019	0.00581	CcSEcCtD
Dextropropoxyphene—Dermatitis—Auranofin—psoriatic arthritis	0.0019	0.0058	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Prednisolone—psoriatic arthritis	0.00186	0.00568	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Betamethasone—psoriatic arthritis	0.0018	0.0055	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Dexamethasone—psoriatic arthritis	0.0018	0.0055	CcSEcCtD
Dextropropoxyphene—Nausea—Auranofin—psoriatic arthritis	0.00179	0.00547	CcSEcCtD
Dextropropoxyphene—Psychotic disorder—Methylprednisolone—psoriatic arthritis	0.00175	0.00535	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Dexamethasone—psoriatic arthritis	0.00172	0.00526	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Betamethasone—psoriatic arthritis	0.00172	0.00526	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Triamcinolone—psoriatic arthritis	0.00171	0.00522	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Methylprednisolone—psoriatic arthritis	0.0017	0.00521	CcSEcCtD
Dextropropoxyphene—Euphoric mood—Prednisone—psoriatic arthritis	0.00168	0.00514	CcSEcCtD
Dextropropoxyphene—Psychotic disorder—Betamethasone—psoriatic arthritis	0.00159	0.00487	CcSEcCtD
Dextropropoxyphene—Psychotic disorder—Dexamethasone—psoriatic arthritis	0.00159	0.00487	CcSEcCtD
Dextropropoxyphene—Cardiac failure congestive—Prednisone—psoriatic arthritis	0.00157	0.00479	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Dexamethasone—psoriatic arthritis	0.00155	0.00474	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Betamethasone—psoriatic arthritis	0.00155	0.00474	CcSEcCtD
Dextropropoxyphene—Coma—Methotrexate—psoriatic arthritis	0.00149	0.00457	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.00148	0.00454	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Prednisolone—psoriatic arthritis	0.00148	0.00451	CcSEcCtD
Dextropropoxyphene—Gastrointestinal haemorrhage—Prednisone—psoriatic arthritis	0.00142	0.00434	CcSEcCtD
Dextropropoxyphene—Psychotic disorder—Prednisone—psoriatic arthritis	0.00139	0.00424	CcSEcCtD
Dextropropoxyphene—Bradycardia—Prednisolone—psoriatic arthritis	0.00138	0.00421	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.00136	0.00417	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.00136	0.00416	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.00136	0.00415	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.00135	0.00414	CcSEcCtD
Dextropropoxyphene—Cardiac arrest—Prednisone—psoriatic arthritis	0.00135	0.00413	CcSEcCtD
Dextropropoxyphene—Visual impairment—Prednisolone—psoriatic arthritis	0.0013	0.00398	CcSEcCtD
Dextropropoxyphene—Bradycardia—Triamcinolone—psoriatic arthritis	0.00127	0.00387	CcSEcCtD
Dextropropoxyphene—Bradycardia—Methylprednisolone—psoriatic arthritis	0.00126	0.00386	CcSEcCtD
Dextropropoxyphene—Visual disturbance—Methotrexate—psoriatic arthritis	0.00125	0.00383	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.00124	0.00379	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.00124	0.00379	CcSEcCtD
Dextropropoxyphene—Hallucination—Methylprednisolone—psoriatic arthritis	0.00123	0.00377	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.00123	0.00377	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Betamethasone—psoriatic arthritis	0.00123	0.00377	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Prednisolone—psoriatic arthritis	0.00121	0.00369	CcSEcCtD
Dextropropoxyphene—Visual impairment—Methylprednisolone—psoriatic arthritis	0.0012	0.00365	CcSEcCtD
Dextropropoxyphene—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00116	0.00354	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.00115	0.00352	CcSEcCtD
Dextropropoxyphene—Bradycardia—Betamethasone—psoriatic arthritis	0.00115	0.00351	CcSEcCtD
Dextropropoxyphene—Bradycardia—Dexamethasone—psoriatic arthritis	0.00115	0.00351	CcSEcCtD
Dextropropoxyphene—Hallucination—Dexamethasone—psoriatic arthritis	0.00112	0.00343	CcSEcCtD
Dextropropoxyphene—Hallucination—Betamethasone—psoriatic arthritis	0.00112	0.00343	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00112	0.00343	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00112	0.00342	CcSEcCtD
Dextropropoxyphene—Ataxia—Methotrexate—psoriatic arthritis	0.00112	0.00341	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Triamcinolone—psoriatic arthritis	0.00111	0.0034	CcSEcCtD
Dextropropoxyphene—Vision blurred—Prednisolone—psoriatic arthritis	0.00111	0.00339	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Methylprednisolone—psoriatic arthritis	0.00111	0.00339	CcSEcCtD
Dextropropoxyphene—Liver function test abnormal—Methotrexate—psoriatic arthritis	0.0011	0.00335	CcSEcCtD
Dextropropoxyphene—Visual impairment—Dexamethasone—psoriatic arthritis	0.00109	0.00332	CcSEcCtD
Dextropropoxyphene—Visual impairment—Betamethasone—psoriatic arthritis	0.00109	0.00332	CcSEcCtD
Dextropropoxyphene—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00108	0.0033	CcSEcCtD
Dextropropoxyphene—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00108	0.0033	CcSEcCtD
Dextropropoxyphene—Myocardial infarction—Prednisone—psoriatic arthritis	0.00107	0.00328	CcSEcCtD
Dextropropoxyphene—Syncope—Prednisolone—psoriatic arthritis	0.00106	0.00323	CcSEcCtD
Dextropropoxyphene—Eye disorder—Betamethasone—psoriatic arthritis	0.00105	0.00322	CcSEcCtD
Dextropropoxyphene—Eye disorder—Dexamethasone—psoriatic arthritis	0.00105	0.00322	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Prednisolone—psoriatic arthritis	0.00103	0.00316	CcSEcCtD
Dextropropoxyphene—Convulsion—Prednisolone—psoriatic arthritis	0.00102	0.00312	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Betamethasone—psoriatic arthritis	0.00101	0.00308	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Dexamethasone—psoriatic arthritis	0.00101	0.00308	CcSEcCtD
Dextropropoxyphene—Bradycardia—Prednisone—psoriatic arthritis	0.001	0.00306	CcSEcCtD
Dextropropoxyphene—Discomfort—Prednisolone—psoriatic arthritis	0.00099	0.00303	CcSEcCtD
Dextropropoxyphene—Hallucination—Prednisone—psoriatic arthritis	0.000977	0.00299	CcSEcCtD
Dextropropoxyphene—Syncope—Triamcinolone—psoriatic arthritis	0.00097	0.00297	CcSEcCtD
Dextropropoxyphene—Syncope—Methylprednisolone—psoriatic arthritis	0.000968	0.00296	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000951	0.00291	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000949	0.0029	CcSEcCtD
Dextropropoxyphene—Shock—Prednisolone—psoriatic arthritis	0.000945	0.00289	CcSEcCtD
Dextropropoxyphene—Convulsion—Triamcinolone—psoriatic arthritis	0.000938	0.00287	CcSEcCtD
Dextropropoxyphene—Tachycardia—Prednisolone—psoriatic arthritis	0.000937	0.00287	CcSEcCtD
Dextropropoxyphene—Convulsion—Methylprednisolone—psoriatic arthritis	0.000935	0.00286	CcSEcCtD
Dextropropoxyphene—Eye disorder—Prednisone—psoriatic arthritis	0.000918	0.00281	CcSEcCtD
Dextropropoxyphene—Drowsiness—Methotrexate—psoriatic arthritis	0.000914	0.0028	CcSEcCtD
Dextropropoxyphene—Discomfort—Triamcinolone—psoriatic arthritis	0.00091	0.00278	CcSEcCtD
Dextropropoxyphene—Discomfort—Methylprednisolone—psoriatic arthritis	0.000908	0.00278	CcSEcCtD
Dextropropoxyphene—Confusional state—Methylprednisolone—psoriatic arthritis	0.000888	0.00272	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Prednisone—psoriatic arthritis	0.000887	0.00271	CcSEcCtD
Dextropropoxyphene—Syncope—Dexamethasone—psoriatic arthritis	0.00088	0.00269	CcSEcCtD
Dextropropoxyphene—Syncope—Betamethasone—psoriatic arthritis	0.00088	0.00269	CcSEcCtD
Dextropropoxyphene—Arrhythmia—Prednisone—psoriatic arthritis	0.000877	0.00268	CcSEcCtD
Dextropropoxyphene—Shock—Triamcinolone—psoriatic arthritis	0.000869	0.00266	CcSEcCtD
Dextropropoxyphene—Insomnia—Prednisolone—psoriatic arthritis	0.000869	0.00266	CcSEcCtD
Dextropropoxyphene—Shock—Methylprednisolone—psoriatic arthritis	0.000867	0.00265	CcSEcCtD
Dextropropoxyphene—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000865	0.00264	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000864	0.00264	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000863	0.00264	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000863	0.00264	CcSEcCtD
Dextropropoxyphene—Tachycardia—Triamcinolone—psoriatic arthritis	0.000862	0.00264	CcSEcCtD
Dextropropoxyphene—Tachycardia—Methylprednisolone—psoriatic arthritis	0.00086	0.00263	CcSEcCtD
Dextropropoxyphene—Malnutrition—Prednisone—psoriatic arthritis	0.000855	0.00261	CcSEcCtD
Dextropropoxyphene—Convulsion—Betamethasone—psoriatic arthritis	0.000851	0.0026	CcSEcCtD
Dextropropoxyphene—Convulsion—Dexamethasone—psoriatic arthritis	0.000851	0.0026	CcSEcCtD
Dextropropoxyphene—Discomfort—Dexamethasone—psoriatic arthritis	0.000826	0.00253	CcSEcCtD
Dextropropoxyphene—Discomfort—Betamethasone—psoriatic arthritis	0.000826	0.00253	CcSEcCtD
Dextropropoxyphene—Hypotension—Methylprednisolone—psoriatic arthritis	0.000823	0.00252	CcSEcCtD
Dextropropoxyphene—Vision blurred—Prednisone—psoriatic arthritis	0.000806	0.00246	CcSEcCtD
Dextropropoxyphene—Insomnia—Triamcinolone—psoriatic arthritis	0.000799	0.00244	CcSEcCtD
Dextropropoxyphene—Insomnia—Methylprednisolone—psoriatic arthritis	0.000797	0.00244	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000791	0.00242	CcSEcCtD
Dextropropoxyphene—Visual impairment—Methotrexate—psoriatic arthritis	0.000791	0.00242	CcSEcCtD
Dextropropoxyphene—Shock—Dexamethasone—psoriatic arthritis	0.000788	0.00241	CcSEcCtD
Dextropropoxyphene—Shock—Betamethasone—psoriatic arthritis	0.000788	0.00241	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000787	0.00241	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000786	0.0024	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000786	0.0024	CcSEcCtD
Dextropropoxyphene—Agitation—Prednisone—psoriatic arthritis	0.000786	0.0024	CcSEcCtD
Dextropropoxyphene—Tachycardia—Betamethasone—psoriatic arthritis	0.000782	0.00239	CcSEcCtD
Dextropropoxyphene—Tachycardia—Dexamethasone—psoriatic arthritis	0.000782	0.00239	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000777	0.00238	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000776	0.00237	CcSEcCtD
Dextropropoxyphene—Eye disorder—Methotrexate—psoriatic arthritis	0.000767	0.00235	CcSEcCtD
Dextropropoxyphene—Syncope—Prednisone—psoriatic arthritis	0.000767	0.00234	CcSEcCtD
Dextropropoxyphene—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000762	0.00233	CcSEcCtD
Dextropropoxyphene—Loss of consciousness—Prednisone—psoriatic arthritis	0.000751	0.0023	CcSEcCtD
Dextropropoxyphene—Hypotension—Dexamethasone—psoriatic arthritis	0.000749	0.00229	CcSEcCtD
Dextropropoxyphene—Hypotension—Betamethasone—psoriatic arthritis	0.000749	0.00229	CcSEcCtD
Dextropropoxyphene—Immune system disorder—Methotrexate—psoriatic arthritis	0.000741	0.00227	CcSEcCtD
Dextropropoxyphene—Convulsion—Prednisone—psoriatic arthritis	0.000741	0.00227	CcSEcCtD
Dextropropoxyphene—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00074	0.00226	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000728	0.00222	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000726	0.00222	CcSEcCtD
Dextropropoxyphene—Insomnia—Dexamethasone—psoriatic arthritis	0.000725	0.00222	CcSEcCtD
Dextropropoxyphene—Insomnia—Betamethasone—psoriatic arthritis	0.000725	0.00222	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000721	0.0022	CcSEcCtD
Dextropropoxyphene—Discomfort—Prednisone—psoriatic arthritis	0.000719	0.0022	CcSEcCtD
Dextropropoxyphene—Malnutrition—Methotrexate—psoriatic arthritis	0.000715	0.00218	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000708	0.00216	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Betamethasone—psoriatic arthritis	0.000705	0.00216	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000705	0.00216	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000697	0.00213	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000692	0.00212	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000692	0.00212	CcSEcCtD
Dextropropoxyphene—Shock—Prednisone—psoriatic arthritis	0.000687	0.0021	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Prednisone—psoriatic arthritis	0.000684	0.00209	CcSEcCtD
Dextropropoxyphene—Tachycardia—Prednisone—psoriatic arthritis	0.000681	0.00208	CcSEcCtD
Dextropropoxyphene—Vision blurred—Methotrexate—psoriatic arthritis	0.000673	0.00206	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00066	0.00202	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00066	0.00202	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000655	0.002	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000655	0.002	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000651	0.00199	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000649	0.00198	CcSEcCtD
Dextropropoxyphene—Dizziness—Prednisolone—psoriatic arthritis	0.000635	0.00194	CcSEcCtD
Dextropropoxyphene—Asthenia—Triamcinolone—psoriatic arthritis	0.000634	0.00194	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Betamethasone—psoriatic arthritis	0.000633	0.00194	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000633	0.00194	CcSEcCtD
Dextropropoxyphene—Asthenia—Methylprednisolone—psoriatic arthritis	0.000632	0.00193	CcSEcCtD
Dextropropoxyphene—Insomnia—Prednisone—psoriatic arthritis	0.000631	0.00193	CcSEcCtD
Dextropropoxyphene—Convulsion—Methotrexate—psoriatic arthritis	0.000619	0.00189	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Prednisone—psoriatic arthritis	0.000614	0.00188	CcSEcCtD
Dextropropoxyphene—Rash—Prednisolone—psoriatic arthritis	0.000605	0.00185	CcSEcCtD
Dextropropoxyphene—Dermatitis—Prednisolone—psoriatic arthritis	0.000605	0.00185	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000603	0.00184	CcSEcCtD
Dextropropoxyphene—Headache—Prednisolone—psoriatic arthritis	0.000602	0.00184	CcSEcCtD
Dextropropoxyphene—Discomfort—Methotrexate—psoriatic arthritis	0.000601	0.00184	CcSEcCtD
Dextropropoxyphene—Constipation—Prednisone—psoriatic arthritis	0.000597	0.00182	CcSEcCtD
Dextropropoxyphene—Confusional state—Methotrexate—psoriatic arthritis	0.000588	0.0018	CcSEcCtD
Dextropropoxyphene—Dizziness—Triamcinolone—psoriatic arthritis	0.000584	0.00179	CcSEcCtD
Dextropropoxyphene—Dizziness—Methylprednisolone—psoriatic arthritis	0.000583	0.00178	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Prednisone—psoriatic arthritis	0.000575	0.00176	CcSEcCtD
Dextropropoxyphene—Asthenia—Dexamethasone—psoriatic arthritis	0.000575	0.00176	CcSEcCtD
Dextropropoxyphene—Asthenia—Betamethasone—psoriatic arthritis	0.000575	0.00176	CcSEcCtD
Dextropropoxyphene—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000572	0.00175	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000571	0.00174	CcSEcCtD
Dextropropoxyphene—Nausea—Prednisolone—psoriatic arthritis	0.00057	0.00174	CcSEcCtD
Dextropropoxyphene—Vomiting—Triamcinolone—psoriatic arthritis	0.000561	0.00172	CcSEcCtD
Dextropropoxyphene—Vomiting—Methylprednisolone—psoriatic arthritis	0.00056	0.00171	CcSEcCtD
Dextropropoxyphene—Rash—Triamcinolone—psoriatic arthritis	0.000557	0.0017	CcSEcCtD
Dextropropoxyphene—Dermatitis—Triamcinolone—psoriatic arthritis	0.000556	0.0017	CcSEcCtD
Dextropropoxyphene—Rash—Methylprednisolone—psoriatic arthritis	0.000556	0.0017	CcSEcCtD
Dextropropoxyphene—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000555	0.0017	CcSEcCtD
Dextropropoxyphene—Headache—Triamcinolone—psoriatic arthritis	0.000553	0.00169	CcSEcCtD
Dextropropoxyphene—Headache—Methylprednisolone—psoriatic arthritis	0.000552	0.00169	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Prednisone—psoriatic arthritis	0.000552	0.00169	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000548	0.00168	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Betamethasone—psoriatic arthritis	0.000548	0.00168	CcSEcCtD
Dextropropoxyphene—Hypotension—Methotrexate—psoriatic arthritis	0.000545	0.00167	CcSEcCtD
Dextropropoxyphene—Dizziness—Dexamethasone—psoriatic arthritis	0.00053	0.00162	CcSEcCtD
Dextropropoxyphene—Dizziness—Betamethasone—psoriatic arthritis	0.00053	0.00162	CcSEcCtD
Dextropropoxyphene—Insomnia—Methotrexate—psoriatic arthritis	0.000527	0.00161	CcSEcCtD
Dextropropoxyphene—Nausea—Triamcinolone—psoriatic arthritis	0.000525	0.0016	CcSEcCtD
Dextropropoxyphene—Nausea—Methylprednisolone—psoriatic arthritis	0.000523	0.0016	CcSEcCtD
Dextropropoxyphene—Dyspnoea—Methotrexate—psoriatic arthritis	0.00052	0.00159	CcSEcCtD
Dextropropoxyphene—Somnolence—Methotrexate—psoriatic arthritis	0.000518	0.00159	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Prednisone—psoriatic arthritis	0.000514	0.00157	CcSEcCtD
Dextropropoxyphene—Dyspepsia—Methotrexate—psoriatic arthritis	0.000513	0.00157	CcSEcCtD
Dextropropoxyphene—Vomiting—Betamethasone—psoriatic arthritis	0.000509	0.00156	CcSEcCtD
Dextropropoxyphene—Vomiting—Dexamethasone—psoriatic arthritis	0.000509	0.00156	CcSEcCtD
Dextropropoxyphene—Rash—Betamethasone—psoriatic arthritis	0.000505	0.00154	CcSEcCtD
Dextropropoxyphene—Rash—Dexamethasone—psoriatic arthritis	0.000505	0.00154	CcSEcCtD
Dextropropoxyphene—Dermatitis—Betamethasone—psoriatic arthritis	0.000505	0.00154	CcSEcCtD
Dextropropoxyphene—Dermatitis—Dexamethasone—psoriatic arthritis	0.000505	0.00154	CcSEcCtD
Dextropropoxyphene—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000503	0.00154	CcSEcCtD
Dextropropoxyphene—Headache—Dexamethasone—psoriatic arthritis	0.000502	0.00153	CcSEcCtD
Dextropropoxyphene—Headache—Betamethasone—psoriatic arthritis	0.000502	0.00153	CcSEcCtD
Dextropropoxyphene—Asthenia—Prednisone—psoriatic arthritis	0.000501	0.00153	CcSEcCtD
Dextropropoxyphene—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000481	0.00147	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Prednisone—psoriatic arthritis	0.000477	0.00146	CcSEcCtD
Dextropropoxyphene—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000477	0.00146	CcSEcCtD
Dextropropoxyphene—Nausea—Dexamethasone—psoriatic arthritis	0.000476	0.00146	CcSEcCtD
Dextropropoxyphene—Nausea—Betamethasone—psoriatic arthritis	0.000476	0.00146	CcSEcCtD
Dextropropoxyphene—Dizziness—Prednisone—psoriatic arthritis	0.000461	0.00141	CcSEcCtD
Dextropropoxyphene—Abdominal pain—Methotrexate—psoriatic arthritis	0.000461	0.00141	CcSEcCtD
Dextropropoxyphene—Vomiting—Prednisone—psoriatic arthritis	0.000444	0.00136	CcSEcCtD
Dextropropoxyphene—Rash—Prednisone—psoriatic arthritis	0.00044	0.00135	CcSEcCtD
Dextropropoxyphene—Dermatitis—Prednisone—psoriatic arthritis	0.00044	0.00134	CcSEcCtD
Dextropropoxyphene—Headache—Prednisone—psoriatic arthritis	0.000437	0.00134	CcSEcCtD
Dextropropoxyphene—Hypersensitivity—Methotrexate—psoriatic arthritis	0.00043	0.00131	CcSEcCtD
Dextropropoxyphene—Asthenia—Methotrexate—psoriatic arthritis	0.000418	0.00128	CcSEcCtD
Dextropropoxyphene—Nausea—Prednisone—psoriatic arthritis	0.000414	0.00127	CcSEcCtD
Dextropropoxyphene—Diarrhoea—Methotrexate—psoriatic arthritis	0.000399	0.00122	CcSEcCtD
Dextropropoxyphene—Dizziness—Methotrexate—psoriatic arthritis	0.000386	0.00118	CcSEcCtD
Dextropropoxyphene—Vomiting—Methotrexate—psoriatic arthritis	0.000371	0.00113	CcSEcCtD
Dextropropoxyphene—Rash—Methotrexate—psoriatic arthritis	0.000368	0.00112	CcSEcCtD
Dextropropoxyphene—Dermatitis—Methotrexate—psoriatic arthritis	0.000367	0.00112	CcSEcCtD
Dextropropoxyphene—Headache—Methotrexate—psoriatic arthritis	0.000365	0.00112	CcSEcCtD
Dextropropoxyphene—Nausea—Methotrexate—psoriatic arthritis	0.000346	0.00106	CcSEcCtD
